Unlock this StockReport nowClick to Unlock

Danaher Share Price

DHR $140.35 3.2  2.3%

Relative Strength (%)
Volume Change (%)
10d v 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
Margin of Safety (beta)
Screens Passed
Balance Sheet · Income Statement · Cashflow Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 TTM 2019E 2020E CAGR / Avg
Revenue $m
Operating Profit $m
Net Profit $m
EPS Reported $
EPS Normalised $
EPS Growth %
PE Ratio x
Operating Margin %
Op. Cashflow ps $
Capex ps $
Free Cashflow ps $
Last ex-div: 27th Jun, paid: 26th Jul more... Dividends
Dividend ps $
Dividend Growth %
Dividend Yield %
Dividend Cover x
Balance Sheet
Cash etc $m
Working Capital $m
Net Fixed Assets $m
Net Debt $m
Book Value $m
Average Shares m
Book Value ps $ +4.6%

FINANCIAL BRIEF: For the six months ended 28 June 2019, Danaher Corporation revenues increased 4% to $10.04B. Net income applicable to common stockholders decreased 16% to $1.04B. Revenues reflect Life sciences segment increase of 8% to $3.34B, DIAGNOSTICS segment increase of 3% to $3.16B, Environmental & Applied Solutions segment increase of 2% to $2.17B. Net income was offset by Other segment loss increase of 79% to $193.9M. more »

Health Trend
Bankruptcy Risk
  Earnings Manipulation Risk
Magic Formula Score
Other Ratios
Leverage (ttm) Total -Intang +Pension
Gross Gearing %
Net Gearing %
Cash / Assets %
Recent History
Latest interim period (ended 28th Jun '19) vs. prior year
Sales Growth %
EPS Growth %
3yr Compound Annual Growth Rate
Sales Growth %
EPS Growth %
DPS Growth %

Broker Forecasts
31st Dec 2019
31st Dec 2020

Price Target: $154.5
(+10.11% above Price)
Net Profit EPS DPS Net Profit EPS DPS
Est. Long Term Growth Rate: +9.3% ($) ($) ($) ($) ($) ($)
Consensus Estimate
1m Change
3m Change
13 brokers Broker Consensus Trend
Broker Recommendations for Danaher
Recommendation:Strong SellSellHoldBuyStrong Buy
No. of Analysts: 0 0 2 7 7

Named Brokers and Analysts
Bank of America Merrill Lynch Andrew Obin , Deutsche Bank Dan Leonard , Janney Montgomery Scott LLC Paul Knight , Cowen and Company Douglas Schenkel , Stifel Nicolaus and Company, Incorporated , Needham & Company Inc. Stephen Unger , Jefferies Brandon Couillard , Credit Suisse - North America Julian Mitchell , RBC Capital Markets Deane Dray , Piper Jaffray William Quirk , Morgan Stanley , Citi , SVB Leerink , Wells Fargo Securities, LLC , Goldman Sachs Research Patrick Donnelly , Argus Research Corporation John Eade , Robert W. Baird & Co. Richard Eastman , William Blair & Company Brian Drab , UBS Equities , JPMorgan Tycho Peterson , Wolfe Research Steve Beuchaw , Barclays Julian Mitchell , Morningstar, Inc. Krzysztof Smalec , EVERCORE ISI Ross Muken , BTIG , Melius Research Scott Davis ,

Profile Summary

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification. As of December 31, 2016, Danaher's research and development, manufacturing, sales, distribution, service and administrative facilities were located in over 60 countries.

Directors: Steven Rales (CHM) 68, Matthew McGrew (CFO) 47, Rainer Blair (EVP) 54, Daniel Comas (EVP) 55, William Daniel (EVP) 54, Joakim Weidemanis (EVP) 49, Robert Lutz (SVP) 61, Brian Ellis (SVP) 52, Angela Lalor (SVP) 53, William King (SVP) 51, Donald Ehrlich (LED) 81, Mitchell Rales (DRC) 62, Linda Hefner Filler (IND) 58, Teri List-Stoll (IND) 56, Walter Lohr, (IND) 75,

No. of Employees: 71,000 No. of Shareholders: 2,500

Last Annual December 31st, 2018
Last Interim June 28th, 2019
Incorporated October 3, 1986
Public Since July 10, 2015
Shares in Issue 717,367,599
Free Float 637.1m (88.8%)
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Eligible for an ISA? a SIPP?

DHR Share Price Performance DHR Share Price Quote
3.2  2.3%
Traded 9:03pm · Minimum 15 min delayed · NMS:

Latest DHR News Announcements (delayed)

Upcoming DHR Events
Tuesday 17th September, 2019
Danaher Corp Water Quality Platform Investor & Analyst Event at Hach
Wednesday 16th October, 2019 (estimate)
Q3 2019 Danaher Corp Earnings Release
Monday 27th January, 2020 (estimate)
Q4 2019 Danaher Corp Earnings Release

Recent ↓
Thursday 18th July, 2019
Q2 2019 Danaher Corp Earnings Call
Thursday 18th July, 2019
Q2 2019 Danaher Corp Earnings Release
Thursday 27th June, 2019
Dividend For DHR.N
Thursday 27th June, 2019
Dividend For DHER34.SA
Thursday 30th May, 2019
Danaher Corp at Sanford C Bernstein Strategic Decisions Conference
Wednesday 15th May, 2019
Danaher Corp at Bank of America Merrill Lynch Health Care Conference
Tuesday 7th May, 2019
Danaher Corp Annual Shareholders Meeting
Thursday 18th April, 2019
Q1 2019 Danaher Corp Earnings Call
Thursday 18th April, 2019
Q1 2019 Danaher Corp Earnings Release
Thursday 28th March, 2019
Dividend For DHR.N
Wednesday 27th March, 2019
Dividend For DHER34.SA
Wednesday 20th February, 2019
Danaher Corp at Barclays Industrial Select Conference
Tuesday 29th January, 2019
Q4 2018 Danaher Corp Earnings Call
Tuesday 29th January, 2019
Q4 2018 Danaher Corp Earnings Release
Tuesday 8th January, 2019
Danaher Corp at JPMorgan Global Healthcare Conference
Thursday 27th December, 2018
Dividend For DHR.N
Thursday 13th December, 2018
Danaher Corp Investor and Analyst Meeting
Tuesday 6th November, 2018
Danaher Corp at Robert W Baird Global Industrial Conference
Thursday 18th October, 2018
Q3 2018 Danaher Corp Earnings Call
Thursday 18th October, 2018
Q3 2018 Danaher Corp Earnings Release

Use of our data service is subject to express Terms of Service. Please see our full site disclaimer for more details. In particular, it is very important to do your own research (DYOR) and seek professional advice before making any investment based on your own personal circumstances. Please note that the information, data and analysis contained within this stock report: (a) include the proprietary information of Stockopedia's third party licensors and Stockopedia; (b) should not be copied or redistributed except as specifically authorised; and (c) are not warranted to be complete, accurate or timely. You should independently research and verify any information that you find in this report. Stockopedia will not be liable in respect of any loss, trading or otherwise, that you may suffer arising out of such information or any reliance you may place upon it. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up. © Stockopedia 2019.

Should you buy DHR

Access DHR Analytics Now!

Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis